Six months later was hospitalized for classical LVF -PND / orthopnoea - which rapidly progressed to class IV - with systemic venous congestion -

Size: px
Start display at page:

Download "Six months later was hospitalized for classical LVF -PND / orthopnoea - which rapidly progressed to class IV - with systemic venous congestion -"

Transcription

1

2 HISTORY 48 years female, on Metformin with history of Diabetes Mellitus was diagnosed to have asymptomatic LV Dysfunction (with normal CAG) during pre-operative evaluation - for scapular injuryin RTA. A diagnosis of Non- ischemic cardiomyopathy was made and discharged on appropriate medication of beta-blockers, ACE I, Diuretics. Being female note on obstretic history and cardiovascular health during pregnancy, would have helpful. Should we stop further investigation and be satisfied with diagnosis of Non ischemic cardiomyopathy.

3 Six months later was hospitalized for classical LVF -PND / orthopnoea - which rapidly progressed to class IV - with systemic venous congestion - Elevated JVP, dependent pitting edema of both lower limbs equally which was confirmed by further Biochemical (NT ProBNP> 2000 Pg/ml) Echo Doppler study- showrd non hypertrophic ventricles and dilated LV cavity with poor LV systolic function (LVEF 33.6%) and RV dysfunction (TAPSE 1.7)

4 HOSPITAL COURSE Hospital course complicated by- Pulmonary embolism (with pulmonary infract on CT chest)- after which IV heparin started Anemia - with low serum iron and markedly increased serum folic acid(> 2000ng/ml) Pulmonary problem -Miliary mottling of both lung fields on HRCT. Inspite of all aggressive medical therapy during hospital stay, she died suddenly on 9th day of admission. In short a case of Heart Failure Progressed from stage B to D in less than six months with clinical/ laboratory evidence of multiple system involvement.

5 ETIOLOGY OF NON ISCHEMIC LV DYSFUNCTION Identifying etiology of Non ischemic LV dysfunction is important, as prognosis and therapy markedly different between various types of dilated cardiomyopthies. Does course of disease give us clue to etiology? The usual case of DCM is insidious onset with slow progression over a period of 5 10 years with survival of 50% at 5years. The patients had rather fulminant course causing death in less than 1year indicative of myocarditis.

6 The challenge of finding correct etiology in patients with CHF is illustrated by studies that compared clinical diagnosis with morphological diagnosis at cardiac transplant. In two large series, spanning two decades each. the percentage of patients with difference in diagnosis - between clinical and morphological - varied from 13-17% - particular with patients in non-ischemic cardiomyopathy % - (approximately one in four being wrongly labeled). The conditions that were missed clinically included myocarditis sarcidosis and non-compaction of LV. In one series of 1230patients, labelled as dilated cardiomyopathy only 50% had idiopathic DCM and 21% had either myocarditis (9%),infiltrative diseases (5%), peripartum cardiomyopathy (4%) and connective tissue disorder (3%), other miscellaneous conditions - HIV infection substance abuse and drug induced or aggravated by oncochemotherapy, forming rest etiology.

7 Diabetes Mellitusis present approximately 15-20% of patients with CHF. Adverse impact of DM on Heart is much more in females. The time from onset of DM to development of CHF is 8.5 years in males to 12.6 years on females.the exact mechanism of Heart Failure in DM is multifactorial.

8 HISTORY AND EXAMINATION Historical and physical exam contribute little to etiological diagnosis of Heart Failure, Acute heart failure after an antecedent flu like illness is suggestive of myocarditis just as alcoholic abuse is suggestive of alcoholic DCM. Similarly past history of prolongedoncochemotherapy - like drugs, for childhood malignancy, might manifest as CHF induced by drugs. during adulthood /Few extra cardiac findings may lead to specific etiology but these are infrequent but should looked for - like peri orbital purpura (for AL type of Amyloidosis) and rare triad of DM, Skin pigmentation and cirrhosis- Hemochromatosis. Involvement of other organs- Skin (Erythema Nodosumin Tuberculosis), Lung (Sarcoid/Pulmonary TB) and Intestine should be carefully looked for etiological clues. When multisystem involvement including Heart occur, as in this patient- infection (Viral/Protocol) infiltrative / degenerative disorder, and vasculitis should be seriously considered.

9 This patients ECG showed sinus rhythm with no evidence of hypertrophy. Low voltage ECG complex should also alert to you, possibility of hypothyroidism, with its adverse impact upon cardiovascular system. Does ECG contribute to etiological diagnosis? This patient had severe rhythm, low voltage in limb( <5mm) and <10mm in pericardial leads) with no significant ST/ T changes.integration of Physical findings with ECG could give clues to etiology of DCM, for example - evidence of LVH - by physical exam with low voltage in limb leads is typical of idiopathic DCM. Just as amyloidosis - where low voltage is seen in both limb and percardial leads. A heart block / AV conduction disturbance is a feature of Infiltrative disorder - Sarcoidosis/ Tuberculosis. Atrial fibrillation with rapid ventricular rate in absence of valvular heart disease, specially in young patients should alertone to possibility of Tachy induced cardiomyopathy.

10 INVESTIGATIONS Blood chemistry in patients with CHF more often reflect consequences of CHF on various organs rather than etiology of CHF. Some of the data may offer prognostic indicators like Hyponatremia and markedly elevated NT- ProBNP with poor response to therapy and severely deranged LFT (indicative of ischemic hepatitis rather than of passive venous congestion). This patient had persistent hyponatremia and progressive worsening of renal function(marker of progressive worsening of cardiac output), indications poor prognosis.

11 Occurrence of anaemia in CHF like in this is patient is also marker of poor prognosis. The prevalence of anaemia in CHF like in SOLVD trial 22% and appears to increase with worsening of NYHA class. Worsening anaemia can contribute to deterioration of CHF.Theetiology of anaemia in CHF is multi-factorial- from poor dietary intake, blood loss consequent to co-administered anti-platelet drugs and poor utilisation of iron due to elevated cytokines, TGF, IL-6 and markedly elevated hepcidin. This patient had rare type of anaemia with markedly elevated serum folic acid(>2000ng/ml) and normal serum vitamin B12 levels. This markedly elevated serum folic acid levels occurs in stagnant bowel loop (blind loop) syndrome, where gut bacteria produce and contribute to markedly elevated folic acid level. This finding is indicative of associated gut disease either stricture, blind loop- in patients with CHF.

12 2D ECHO 2D echo with Doppler cannot only confirm the clinical suspicion of systolic heart failure, by low EF, but also etiology-valvular pathology, pericardiac disease, endocardiac and myocardial disorder. It is a good imaging technology, where thickness of muscle and cavity size, and myocardial texture, in addition to hemodynamic data cardiac output,filling pressuresis available. Disproportionate RV/RA dilation and dysfunction in patients with left heart disease should raise suspicious of associated pulmonary embolism like in this patient. Incidence of PTE in CHF is approximately twice that of non CHF patient are mainly due to immobility and venous stasis (due to low cardiac output). This patient has PTE with pulmonary infarct (as in HRCT), also aggravated arterial hypoxia(spo2: 90%). Generally subsegmental PTE has no significant impact in patients without any underlying CV disease. But in patients who has underlying heart disease can cause hemodynamic perturbation.this could have been prevented by prophylactic heparin(ufh in patients with CKD)

13 This patient echo is characterized by Global Hypokinesia (LVEF 33.6%) with normal myocardial thickness. PH(RVSP=58) with severe TR and RV dysfunction (TAPSE 1.7). Cardiac valves and pericardium were reported to be normal. The occurrence of PH in patients with cardiomyopathy is approximately 60%. The prevalence and impact of PH on prognosis seem to depend on type of myopathy, with worse impact (higher mortality) in patients with myocarditis than other type of cardiomyopathy.

14 Should we investigate all patients, for potential salvageable patients like myocarditis or diseases? If so what is the approach to etiologic diagnosis? The answer is yes and it involves three staged diagnostic process (ESC-2015guidlines) Stage I- (SCREENING) Stage II- Identification of diagnosable causes Stage III- Establishing etiology of Idiopathic dilated causes to differentiate between two main causes of Idiopathic DCM- 1) Genetic 2) Inflammation/autoimmune

15 Symptomatic heart failure (HF) + left ventricular systolic dysfunction (LVSD) Exlusion Of CAD -CAG echocardiographyprimary heart valve disease & Congestive heart Disease Arterial hypertension history + additional tests Dialated cardiopathy(dcm) exclusion of other types of cardiomyopathy medications- induced cardiomyopathy connective tissue diseases tachycardia induced cardiomyopathy endocrinologic disorders infiltrative diseases toxins induced cardiomyopathy other miscellaneous causes Idiopathic dilated cardiomyopathy (IDCM)

16 This patient with Diabetes Mellitus had multiorgan involvement- HEART, Lung, Intestine which makes one consider granulomatous carditis as a distinct possibility like sarcoidosis and Tuberculosis. The possibility of Tuberculosis is high due to following reasons: Patient is Diabetic HRCT- of chest at Basal slice is suggestive of tree in bud appearance which characterises endobronchial spread of infection. The slice at subcarinal level shows mass probably lymph nodes. No data is available regarding further pursuance of mass Biopsy, PET scan etc.

17 Myocardial involvement by mycobacteria before era of chemotherapy has been reported in range of 0.3% at autopsy, most commonly pericardium and rarely myocardium.three different types of myocardial involvement has been described- Diffuse infiltrative miliary and nodular (Tuberculoma). Extra pulmonary site is seen in only 25% cases. The best imaging modality for diagnosis of diffuse infiltrative type (likely to cause LV systolic Dysfunction) MRI imaging with short T1 inversion recovery. The image shows edema of myocardium and fibrosis of epicardium. The spread of disease is either by haematogenous route or by contiguous from adjacent lymph nodes, and in some by nirtograde spread via lymphatic presenting symptoms include systolic ventricular dysfunction (LVF) or ventricular dysarrhythmias.

18 Immediate cause of death Arrhythmias : LV systolic dysfunction with EF <35%. Recurrence of PTE inspite of UFH therapeutic failure rate - approximately 3.5% FINAL DIAGNOSIS: LV Systolic Dysfunction probably due to granulomatous myocarditis. Complicated by PTE sub segmental with pulmonary infarct Diabetes Mellitus Stagnant loop syndrome.

19 THANK YOU

CPC OF YOUNG FEMALE WITH CARDIO PULMANARY DISEASE

CPC OF YOUNG FEMALE WITH CARDIO PULMANARY DISEASE INDIAN JOURNAL OF CARDIOVASCULAR DISEASES JOURNAL in women (IJCD) 2017 VOL 2 ISSUE 1 CPC 1 CPC OF YOUNG FEMALE WITH CARDIO PULMANARY DISEASE V. Daya Sagar Rao A 48 years-old female patient presented to

More information

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF

Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF CLASSIFICATION OF HEART FAILURE Nora Goldschlager, M.D. SFGH Division of Cardiology UCSF DISCLOSURES: NONE CLASSIFICATION C OF HEART FAILURE NYHA I IV New paradigm Stage A: Pts at high risk of developing

More information

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output

Heart Failure. Cardiac Anatomy. Functions of the Heart. Cardiac Cycle/Hemodynamics. Determinants of Cardiac Output. Cardiac Output Cardiac Anatomy Heart Failure Professor Qing ZHANG Department of Cardiology, West China Hospital www.blaufuss.org Cardiac Cycle/Hemodynamics Functions of the Heart Essential functions of the heart to cover

More information

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef

Review of Cardiac Imaging Modalities in the Renal Patient. George Youssef Review of Cardiac Imaging Modalities in the Renal Patient George Youssef ECHO Left ventricular hypertrophy (LVH) assessment Diastolic dysfunction Stress ECHO Cardiac CT angiography Echocardiography - positives

More information

Is it HF secondary to rheumatic heart disease???

Is it HF secondary to rheumatic heart disease??? Is it HF secondary to rheumatic heart disease??? Is mitral regurg. Is complication of CHF??? Cardiomyopathy Definition The term cardiomyopathy is purely descriptive, meaning disease of the heart muscle

More information

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό

Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Μαρία Μπόνου Διευθύντρια ΕΣΥ, ΓΝΑ Λαϊκό Diastolic HF DD: Diastolic Dysfunction DHF: Diastolic HF HFpEF: HF with preserved EF DD Pathophysiologic condition: impaired relaxation, LV compliance, LV filling

More information

Cardiac Sarcoidosis. Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascluar

Cardiac Sarcoidosis. Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascluar Cardiac Sarcoidosis Millee Singh DO Non Invasive Cardiology First Coast Heart and Vascluar Introduction Multisystem granulomatous disease of unknown etiology characterized by noncaseating granulomas in

More information

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification

4/11/2017. Cardiomyopathy. John Steuter, MD Bryan Heart. Disclosures. No Conflicts. Cardiomyopathy. WHO Classification Cardiomyopathy John Steuter, MD Bryan Heart Disclosures No Conflicts Cardiomyopathy WHO Classification Anatomy & physiology of the LV 1. Dilated Enlarged Systolic dysfunction 2. Hypertrophic Thickened

More information

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement

Cardiomyopathy. Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Cardiomyopathy Jeff Grubbe MD FACP, Chief Medical Director, Allstate Life & Retirement Nebraska Home Office Life Underwriters Association March 20, 2018 1 Cardiomyopathy A myocardial disorder in which

More information

Case based learning: CMR in Heart Failure

Case based learning: CMR in Heart Failure Case based learning: CMR in Heart Failure Milind Y Desai, MD FACC FAHA FESC Associate Professor of Medicine Heart and Vascular Institute, Cleveland Clinic Cleveland, OH Disclosures: none Use of Gadolinium

More information

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD

Imaging in Heart Failure: A Multimodality Approach. Thomas Ryan, MD Imaging in Heart Failure: A Multimodality Approach Thomas Ryan, MD Heart Failure HFrEF HFpEF EF50% Lifetime risk 20% Prevalence 6M Americans Societal costs - $30B 50% 5-year survival 1 Systolic

More information

Peripartum Cardiomyopathy. Lavanya Rai Manipal

Peripartum Cardiomyopathy. Lavanya Rai Manipal Peripartum Cardiomyopathy Lavanya Rai Manipal Definition - PPCM - Dilated cardiomyopathy of unknown cause resulting in cardiac failure that occurs in the peripartum period in women without any preexisting

More information

Cardiovascular manifestations of HIV

Cardiovascular manifestations of HIV Cardiovascular manifestations of HIV Prabhakar Rajiah, MBBS, MD, FRCR Associate Professor of Radiology Associate Director, Cardiac CT and MRI University of Texas Southwestern Medical Center, Dallas, USA

More information

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational

ADVANCED CARDIOVASCULAR IMAGING. Medical Knowledge. Goals and Objectives PF EF MF LF Aspirational Medical Knowledge Goals and Objectives PF EF MF LF Aspirational Know the basic principles of magnetic resonance imaging (MRI) including the role of the magnetic fields and gradient coil systems, generation

More information

Heart Failure. Dr. William Vosik. January, 2012

Heart Failure. Dr. William Vosik. January, 2012 Heart Failure Dr. William Vosik January, 2012 Questions for clinicians to ask Is this heart failure? What is the underlying cause? What are the associated disease processes? Which evidence-based treatment

More information

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER:

ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM. General Instructions: ID NUMBER: FORM NAME: H F A DATE: 10/13/2017 VERSION: CONTACT YEAR NUMBER: ARIC HEART FAILURE HOSPITAL RECORD ABSTRACTION FORM General Instructions: The Heart Failure Hospital Record Abstraction Form is completed for all heart failure-eligible cohort hospitalizations. Refer to

More information

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept

Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept Heart Failure Dr ahmed almutairi Assistant professor internal medicin dept (MBBS)(SBMD) Introduction Epidemiology Pathophysiology diastolic/systolic Risk factors Signs and symptoms Classification of HF

More information

Value of echocardiography in chronic dyspnea

Value of echocardiography in chronic dyspnea Value of echocardiography in chronic dyspnea Jahrestagung Schweizerische Gesellschaft für /Schweizerische Gesellschaft für Pneumologie B. Kaufmann 16.06.2016 Chronic dyspnea Shortness of breath lasting

More information

Etiology, Classification & Management. Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London

Etiology, Classification & Management. Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London Etiology, Classification & Management Sheba Medical Center Cardiology Department Matthew Wright St. George s University of London Introduction World Health Organization (1995): Diseases of myocardium (heart

More information

Granulomatous Myocarditis - An overlooked cause of cardiomyopathy

Granulomatous Myocarditis - An overlooked cause of cardiomyopathy Granulomatous Myocarditis - An overlooked cause of cardiomyopathy C.Narasimhan CARE Hospital Hyderabad.India. Feb 2015, Medanta, New Delhi Outline: Background Our experience ( When to suspect, How to confirm)

More information

CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology

CARDIOMYOPATHY IN CT. Hans- Christoph Becker Professor of Radiology CARDIOMYOPATHY IN CT Hans- Christoph Becker Professor of Radiology 1 Cardiomyopathy Heart muscle disease Deterioration of the heart function, heart failure Dyspnea, peripheral edema Risk of arrhythmia,

More information

The right heart: the Cinderella of heart failure

The right heart: the Cinderella of heart failure The right heart: the Cinderella of heart failure Piotr Ponikowski, MD, PhD, FESC Medical University, Centre for Heart Disease Clinical Military Hospital Wroclaw, Poland none Disclosure Look into the Heart

More information

Cardiac MRI: Clinical Application to Disease

Cardiac MRI: Clinical Application to Disease Cardiac MRI: Clinical Application to Disease Jessi Smith, MD Cardiothoracic imaging, Indiana University Slides courtesy of Stacy Rissing, MD Outline Imaging planes Disease findings Pulse sequences used

More information

Heart failure for syndicate

Heart failure for syndicate Heart failure for syndicate By M.Wafaie Aboleineen,MD,FACC ESC Guidelines for the diagnosis and treatment of heart failure Part I 1 4 2 Common ECG abnormalities in HF 3 Common CXR abnormalities in HF Common

More information

The NEW Heart Failure Guidelines

The NEW Heart Failure Guidelines The NEW Heart Failure Guidelines Daily Practice HF scenario of the Case Presentations HF as a complex and heterogeneous syndrome Several proposed pathophysiological mechanisms involving the heart and the

More information

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure

ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure Patients t with acute heart failure frequently develop chronic heart failure Patients with chronic heart failure frequently decompensate acutely ESC Guidelines for the Diagnosis and A clinical response

More information

Cardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI

Cardiomyopathy. ACOI IM Board Review 2018 Martin C. Burke DO, FACOI Cardiomyopathy ACOI IM Board Review 2018 Martin C. Burke DO, FACOI No Disclosures Cardiomyopathies Definition: diseases of heart muscle 1980 WHO: unknown causes Not clinically relevant 1995 WHO: diseases

More information

Congestive Heart Failure or Heart Failure

Congestive Heart Failure or Heart Failure Congestive Heart Failure or Heart Failure Dr Hitesh Patel Ascot Cardiology Group Heart Failure Workshop April, 2014 Question One What is the difference between congestive heart failure and heart failure?

More information

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta

Diagnosis & Management of Heart Failure. Abena A. Osei-Wusu, M.D. Medical Fiesta Diagnosis & Management of Heart Failure Abena A. Osei-Wusu, M.D. Medical Fiesta Learning Objectives: 1) Become familiar with pathogenesis of congestive heart failure. 2) Discuss clinical manifestations

More information

Pathophysiology: Heart Failure

Pathophysiology: Heart Failure Pathophysiology: Heart Failure Mat Maurer, MD Irving Assistant Professor of Medicine Outline Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology Heart Failure: Definitions

More information

Heart Failure Overview. Dr Chris K Y Wong

Heart Failure Overview. Dr Chris K Y Wong Heart Failure Overview Dr Chris K Y Wong Heart Failure: A Growing, Global Health Issue Heart Failure 23 Million Afflicted Global Impact Worldwide ~23 million peopleworldwide afflicted with CHF 1 Exceeds

More information

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on)

Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) Evalua&on)of)Le-)Ventricular)Diastolic) Dysfunc&on)by)Echocardiography:) Role)of)Ejec&on)Frac&on) N.Koutsogiannis) Department)of)Cardiology) University)Hospital)of)Patras)! I have no conflicts of interest

More information

2

2 1 2 Although the term "cardiomyopathy" could theoretically apply to almost any disease affecting the heart, it is usually reserved for "severe myocardial disease leading to heart failure".cardiomyopathy

More information

Innovation therapy in Heart Failure

Innovation therapy in Heart Failure Innovation therapy in Heart Failure P. Laothavorn September 2015 Topics of discussion Basic Knowledge about heart failure Standard therapy New emerging therapy References: standard Therapy in Heart Failure

More information

Susan P. D Anna MSN, APRN BC February 14, 2019

Susan P. D Anna MSN, APRN BC February 14, 2019 Is there Equal Opportunity in Heart Failure?? Susan P. D Anna MSN, APRN BC February 14, 2019 Disclosures: I have no financial disclosures. I am not an expert on this topic, but see a lot of women with

More information

Clinical history. 73 yo man with chest pain Systemic hypertension and WG Stress EKG N Stress echocardiogram: Cardiac catheterization: no CAD

Clinical history. 73 yo man with chest pain Systemic hypertension and WG Stress EKG N Stress echocardiogram: Cardiac catheterization: no CAD CASE 8 Clinical history 73 yo man with chest pain Systemic hypertension and WG Stress EKG N Stress echocardiogram: Concentric hypertrophy Hypokinesis of LV-Inf Cardiac catheterization: no CAD Technique

More information

Cardiac MRI: Clinical Application to Disease

Cardiac MRI: Clinical Application to Disease Cardiac MRI: Clinical Application to Disease Stacy Rissing, MD! Cardiothoracic imaging, Indiana University! Outline Imaging planes Disease findings Pulse sequences used for each indication Pathophysiology

More information

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies

Outline. Pathophysiology: Heart Failure. Heart Failure. Heart Failure: Definitions. Etiologies. Etiologies Outline Pathophysiology: Mat Maurer, MD Irving Assistant Professor of Medicine Definitions and Classifications Epidemiology Muscle and Chamber Function Pathophysiology : Definitions An inability of the

More information

Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT

Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Charles Spencer MD, FRCP Consultant Cardiologist Mid Staffs NHSFT Key Messages Heart Failure is Common Heart failure is complex Heart Failure is a major issue for the NHS Heart Failure has a worse prognosis

More information

Acute Pulmonary edema Secondary to CARDIAC FAILURE NON COMPACTED LEFT VENTRICLE in Pregnancy

Acute Pulmonary edema Secondary to CARDIAC FAILURE NON COMPACTED LEFT VENTRICLE in Pregnancy Acute Pulmonary edema Secondary to CARDIAC FAILURE NON COMPACTED LEFT VENTRICLE in Pregnancy Dr Anisha Gala, Consultant Obstetrician Dr. Tarakeswari S HOD, Dept of Obstetric Medicine, Fernandez Hospitals

More information

Cardiomyopathy in Fabry s disease

Cardiomyopathy in Fabry s disease Cardiomyopathy in Fabry s disease Herzinsuffizienzlunch Basel, 11.09.2018 Christiane Gruner Kardiologie, UniversitätsSpital Zürich Content Background / epidemiology Differential diagnosis Clinical presentations

More information

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and

1. LV function and remodeling. 2. Contribution of myocardial ischemia due to CAD, and 1 The clinical syndrome of heart failure in adults is commonly associated with the etiologies of ischemic and non-ischemic dilated cardiomyopathy, hypertrophic cardiomyopathy, hypertensive heart disease,

More information

Restrictive Cardiomyopathy

Restrictive Cardiomyopathy ESC Congress 2011, Paris Imaging Unusual Causes of Cardiomyopathy Restrictive Cardiomyopathy Kazuaki Tanabe, MD, PhD Professor of Medicine Chair, Division of Cardiology Izumo, Japan I Have No Disclosures

More information

HEART FAILURE. Study day November 2018 Sarah Briggs

HEART FAILURE. Study day November 2018 Sarah Briggs HEART FAILURE Study day November 2018 Sarah Briggs Overview and Introduction This course is an introduction and overview of heart failure. Normal heart function and basic pathophysiology of heart failure

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

The new Guidelines: Focus on Chronic Heart Failure

The new Guidelines: Focus on Chronic Heart Failure The new Guidelines: Focus on Chronic Heart Failure Petros Nihoyannopoulos MD, FRCP, FESC Professor of Cardiology Imperial College London and National & Kapodistrian University of Athens 2 3 4 The principal

More information

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan

Role of Stress Echo in Valvular Heart Disease. Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Role of Stress Echo in Valvular Heart Disease Satoshi Nakatani Osaka University Graduate School of Medicine Osaka, Japan Exercise echocardiography Dobutamine echocardiography Usefulness of exercise echo

More information

A patient with decompensated HF

A patient with decompensated HF A patient with decompensated HF Professor Michel KOMAJDA University Pierre & Marie Curie Pitie Salpetriere Hospital Department of Cardiology Paris (France) Declaration Of Interest 2010 Speaker : Servier,

More information

U N I V E R S I T Ä T S M E D I Z I N B E R L I N CBF KARDIOLOGIE

U N I V E R S I T Ä T S M E D I Z I N B E R L I N CBF KARDIOLOGIE U N I V E R S I T Ä T S M E D I Z I N B E R L I N I have nothing to disclose. Case 2 A Case of acute heart failure 54 year old female Patient with acute heart failure and ventricular tachycardia 53 year

More information

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea

CT for Myocardial Characterization of Cardiomyopathy. Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea CT for Myocardial Characterization of Cardiomyopathy Byoung Wook Choi, Yonsei University Severance Hospital, Seoul, Korea Cardiomyopathy Elliott P et al. Eur Heart J 2008;29:270-276 The European Society

More information

Genetic Cardiomyopathies

Genetic Cardiomyopathies 2017 HFCT Annual Scientific Meeting The Heart Failure Crosstalk Genetic Cardiomyopathies Teerapat Yingchoncharoen M.D. Ramathibodi Hospital Cardiomyopathy Group of diseases of the myocardium associated

More information

Cardiac Considerations and Care in Children with Neuromuscular Disorders

Cardiac Considerations and Care in Children with Neuromuscular Disorders Cardiac Considerations and Care in Children with Neuromuscular Disorders - importance of early and ongoing treatment, management and available able medications. Dr Bo Remenyi Department of Cardiology The

More information

What s New in Cardiac MRI

What s New in Cardiac MRI What s New in Cardiac MRI Katie M. Hawthorne, MD Director, Cardiac MRI Main Line Health Philadelphia Cardiovascular Summit November 18, 2017 Cardiac MRI: Disclosure 2 Disclosures No financial disclosures

More information

NT-proBNP: Evidence-based application in primary care

NT-proBNP: Evidence-based application in primary care NT-proBNP: Evidence-based application in primary care Associate Professor Rob Doughty The University of Auckland, Auckland City Hospital, Auckland Heart Group NT-proBNP: Evidence in Primary Care The problem

More information

Topic Page: congestive heart failure

Topic Page: congestive heart failure Topic Page: congestive heart failure Definition: congestive heart f ailure from Merriam-Webster's Collegiate(R) Dictionary (1930) : heart failure in which the heart is unable to maintain an adequate circulation

More information

Therapeutic Targets and Interventions

Therapeutic Targets and Interventions Therapeutic Targets and Interventions Ali Valika, MD, FACC Advanced Heart Failure and Pulmonary Hypertension Advocate Medical Group Midwest Heart Foundation Disclosures: 1. Novartis: Speaker Honorarium

More information

The Causes of Heart Failure

The Causes of Heart Failure The Causes of Heart Failure Andy Birchall HFSN Right heart failure LVSD - HFREF Valve regurgitation or stenosis Dropsy CCF congestive cardiac failure Cor pulmonale Pulmonary hypertension HFPEF LVF Definitions

More information

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death

Why guess when you could know? Gold Standard. Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death Why guess when you could know? Gold Standard Cardiac catheterization (Angiogram) Invasive Risks: Infection, hematoma, death PCI decisions Number of vessels involved Surgeon experience level The anatomic

More information

Pulmonary Hypertension: Another Use for Viagra

Pulmonary Hypertension: Another Use for Viagra Pulmonary Hypertension: Another Use for Viagra Kathleen Tong, MD Director, Heart Failure Program Assistant Clinical Professor University of California, Davis Disclosures I have no financial conflicts A

More information

Assessment and Diagnosis of Heart Failure

Assessment and Diagnosis of Heart Failure Assessment and Diagnosis of Heart Failure Heart failure (HF) is a complex clinical syndrome resulting from any structural or functional impairment of ventricular filling or ejection of blood and is characterized

More information

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016

Echocardiographic Evaluation of the Cardiomyopathies. Stephanie Coulter, MD, FACC, FASE April, 2016 Echocardiographic Evaluation of the Cardiomyopathies Stephanie Coulter, MD, FACC, FASE April, 2016 Cardiomyopathies (CMP) primary disease intrinsic to cardiac muscle Dilated CMP Hypertrophic CMP Infiltrative

More information

Case 5 15-year-old male

Case 5 15-year-old male Case 5 15-year-old male Present illness: Six months ago, abnormality of ECG was incidentally detected by annual health check. His blood level of γ-gtp, HbA1c and norepinephrine were elevated; however,

More information

Cardiomyopathy: The Good, the Bad.and the Insurable?

Cardiomyopathy: The Good, the Bad.and the Insurable? Cardiomyopathy: The Good, the Bad.and the Insurable? WAHLU Spring Seminar 2014 Joy Geiger, RN, BSN, ALMI Medical Consultant The Northwestern Mutual Life Insurance Company Milwaukee, WI Objectives Overview

More information

State-of-the-Art Management of Chronic Systolic Heart Failure

State-of-the-Art Management of Chronic Systolic Heart Failure State-of-the-Art Management of Chronic Systolic Heart Failure Michael McCulloch, MD 17 th Annual Cardiovascular Update Intermountain Medical Center December 16, 2017 Disclosures: I have no financial disclosures

More information

HFpEF. April 26, 2018

HFpEF. April 26, 2018 HFpEF April 26, 2018 (J Am Coll Cardiol 2017;70:2476 86) HFpEF 50% or more (40-71%) of patients with CHF have preserved LV systolic function. HFpEF is an increasingly frequent hospital discharge. Outcomes

More information

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre

Heart Failure in Women: Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Heart Failure in Women: More than EF? Dr Goh Ping Ping Cardiologist Asian Heart & Vascular Centre Overview Review pathophysiology as it relates to diagnosis and management Rational approach to workup:

More information

Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment

Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment ESC 2012 27Aug - 3Sep, 2012, Munich, Germany Treating the patient with acute heart failure. What do we really know? Principles of acute heart failure treatment Marco Metra, MD, FESC Cardiology University

More information

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009

Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 www.ivis.org Proceedings of the 34th World Small Animal Veterinary Congress WSAVA 2009 São Paulo, Brazil - 2009 Next WSAVA Congress : Reprinted in IVIS with the permission of the Congress Organizers MANAGEMENT

More information

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview

Pediatrics. Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment. Overview Pediatrics Arrhythmias in Children: Bradycardia and Tachycardia Diagnosis and Treatment See online here The most common form of cardiac arrhythmia in children is sinus tachycardia which can be caused by

More information

The use of Cardiac CT and MRI in Clinical Practice

The use of Cardiac CT and MRI in Clinical Practice The use of Cardiac CT and MRI in Clinical Practice Matthew W. Martinez, MD Assistant Professor of Medicine LVPG - Lehigh Valley Heart Specialists Lehigh Valley Health Network Oct. 3, 2009 DISCLOSURE Relevant

More information

Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function

Objectives. Let s start at the beginning 10/28/2014. What is Heart Failure? Understanding Heart Failure with Preserved LV Systolic Function Understanding Heart Failure with Preserved LV Systolic Function Eric Ernst, MD Medical Director C.O.R.E. Clinic Objectives Clarify the terminology surrounding right heart failure and diastolic heart failure

More information

New Agents for Heart Failure: Ivabradine Jeffrey S. Borer, MD

New Agents for Heart Failure: Ivabradine Jeffrey S. Borer, MD New Agents for Heart Failure: Ivabradine Jeffrey S. Borer, MD Professor of Medicine, Cell Biology, Radiology and Surgery Director, The Howard Gilman Institute for Heart Valve Disease and the Schiavone

More information

Management of new-onset AF: Initial rate control treatment

Management of new-onset AF: Initial rate control treatment Geneva Acute Crdiovascular Care Congress 2014 - October 18-20, 2014 Management of new-onset AF: Initial rate control treatment Antonio Raviele, MD, FESC, FHRS ALFA Alliance to Fight Atrial fibrillation,

More information

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches

Estimated 5.7 million Americans with HF. 915, 000 new HF cases annually, HF incidence approaches Heart Failure: Management of a Chronic Disease Jenny Bauerly RN, CHFN, APRN-BC Heart Failure (HF) Definition A complex clinical syndrome that can result from any structural or functional cardiac disorder

More information

March yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months

March yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months Case 1 March 2016 59 yr. old male, newspaper writer, with worsening dyspnea /orthopnea past few months PMH diabetes, celiac disease Reports chest discomfort, positional coughing and pedal edema last 10

More information

Heart Failure. Jay Shavadia

Heart Failure. Jay Shavadia Heart Failure Jay Shavadia Definition Clinical syndrome characterized by: Symptoms: breathlessness at rest or on exercise, fatigue, tiredness or ankle swelling AND Signs: tachycardia, tachypnea, pulmonary

More information

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine

Cardiomyopathy. Cardiomyopathies HOCM. Hypertrophic Obstructive Cardiomyopathy. Systolic Anterior Movement (SAM) of Mitral Valve (Venturi Effect) Cine Jens Bremerich Radiology University Hospital Basel Hypertrophic Obstructive Cine VENC Cine (5m/s) Modified Bernoulli Equation: P (in mmhg) = 4 x (Vmax)2 Vmax= 4.2 m/s, P = 70mm Hg Hydrodynamica 738 HOCM

More information

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC

Ventricular Tachycardia Ablation. Saverio Iacopino, MD, FACC, FESC Ventricular Tachycardia Ablation Saverio Iacopino, MD, FACC, FESC ü Ventricular arrhythmias, both symptomatic and asymptomatic, are common, but syncope and SCD are infrequent initial manifestations of

More information

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides Colette Seifer MB(Hons) FRCP(UK) Associate Professor, University of Manitoba, Cardiologist, Cardiac Sciences Program, St Boniface Hospital

More information

Valvular Heart Disease Mitral Stenosis

Valvular Heart Disease Mitral Stenosis Valvular Heart Disease Mitral Stenosis A 75 year old woman with loud first heart sound and mid-diastolic murmur Chronic dyspnea Class 2/4 Fatigue Recent orthopnea/pnd Nocturnal palpitation Pedal edema

More information

UPDATE HEART FAILURE MANAGEMENT

UPDATE HEART FAILURE MANAGEMENT Save Thais from Heart Diseases 2019 UPDATE HEART FAILURE MANAGEMENT Orawan Anupraiwan, MD. Central Chest Institute of Thailand Definition of HF Heart failure is a clinical syndrome characterized by typical

More information

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI)

Acute Coronary Syndromes Unstable Angina Non ST segment Elevation MI (NSTEMI) ST segment Elevation MI (STEMI) Leanna R. Miller, RN, MN, CCRN-CSC, PCCN-CMC, CEN, CNRN, CMSRN, NP Education Specialist LRM Consulting Nashville, TN Objectives Evaluate common abnormalities that mimic myocardial infarction. Identify

More information

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology

Managing Hypertrophic Cardiomyopathy with Imaging. Gisela C. Mueller University of Michigan Department of Radiology Managing Hypertrophic Cardiomyopathy with Imaging Gisela C. Mueller University of Michigan Department of Radiology Disclosures Gadolinium contrast material for cardiac MRI Acronyms Afib CAD Atrial fibrillation

More information

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen

HYPERTROPHY: Behind the curtain. V. Yotova St. Radboud Medical University Center, Nijmegen HYPERTROPHY: Behind the curtain V. Yotova St. Radboud Medical University Center, Nijmegen Disclosure of interest: none Relative wall thickness (cm) M 0.22 0.42 0.43 0.47 0.48 0.52 0.53 F 0.24 0.42 0.43

More information

Heart Failure Overview. Dr Chris K Y Wong

Heart Failure Overview. Dr Chris K Y Wong Heart Failure Overview Dr Chris K Y Wong Heart Failure: A Growing, Global Health Issue Heart Failure 23 Million Afflicted Global Impact Worldwide ~23 million peopleworldwide afflicted with CHF 1 Exceeds

More information

Adult Echocardiography Examination Content Outline

Adult Echocardiography Examination Content Outline Adult Echocardiography Examination Content Outline (Outline Summary) # Domain Subdomain Percentage 1 2 3 4 5 Anatomy and Physiology Pathology Clinical Care and Safety Measurement Techniques, Maneuvers,

More information

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure

Chapter 10. Learning Objectives. Learning Objectives 9/11/2012. Congestive Heart Failure Chapter 10 Congestive Heart Failure Learning Objectives Explain concept of polypharmacy in treatment of congestive heart failure Explain function of diuretics Learning Objectives Discuss drugs used for

More information

Highlights from EuroEcho 2009 Echo in cardiomyopathies

Highlights from EuroEcho 2009 Echo in cardiomyopathies Highlights from EuroEcho 2009 Echo in cardiomyopathies Bogdan A. Popescu University of Medicine and Pharmacy, Bucharest, Romania ESC Congress 2010 Hypertrophic cardiomyopathy To determine the differences

More information

2/4/2011. Nathan Kerner, M.D.

2/4/2011. Nathan Kerner, M.D. Nathan Kerner, M.D. Definition Elevated pressures - cut off usually >40 mmhg pulmonary artery systolic pressure (PASP) Usually associated with elevated pulmonary vascular resistance (PVR) measured in dynessec/cm

More information

QCVC Committees Scientific Activities Central Hall General Information FAC. SPECT tomography has the advantage of quantifying biventricular volumes.

QCVC Committees Scientific Activities Central Hall General Information FAC. SPECT tomography has the advantage of quantifying biventricular volumes. QCVC Committees Scientific Activities Central Hall General Information FAC Thematic Units Arrhythmias and Electrophysiology Basic Research Bioengineering and Medical Informatics Cardiac Surgical Intensive

More information

Heart 101. Objectives. Types of Heart Failure How common is HF? Sign/Symptoms, when to see a doctor? Diagnostic testing

Heart 101. Objectives. Types of Heart Failure How common is HF? Sign/Symptoms, when to see a doctor? Diagnostic testing EXAMING HEART FAILURE: HOW TO RECOGNIZE AND TREAT THE WEAK HEART What is Heart Failure? Treatment of Heart Failure End Stage Heart Failure Munir S. Janmohamed M.D. FACC Assistant Clinical Professor of

More information

An Uncommon Cardiac Etiology of Liver Cirrhosis, Recurrent Ascites, Atrial Fibrillation and Congestive Heart Failure

An Uncommon Cardiac Etiology of Liver Cirrhosis, Recurrent Ascites, Atrial Fibrillation and Congestive Heart Failure Cronicon OPEN ACCESS EC CARDIOLOGY Case Report An Uncommon Cardiac Etiology of Liver Cirrhosis, Recurrent Ascites, Atrial Fibrillation and Congestive Heart Failure Montaser Y Ismail 1 *, Mohammed I Nassar

More information

2016 ESC Heart Failure Guidelines: what is new? Piotr Ponikowski Wroclaw, Poland

2016 ESC Heart Failure Guidelines: what is new? Piotr Ponikowski Wroclaw, Poland 2016 ESC Heart Failure Guidelines: what is new? Piotr Ponikowski Wroclaw, Poland Disclosures Consultancy fees and speaker s honoraria from: Amgen, Servier, Novartis, Johnson & Johnson, Merck, Berlin Chemie,

More information

Diagnostic approach to cardiac amyloidosis: A case report

Diagnostic approach to cardiac amyloidosis: A case report Diagnostic approach to cardiac amyloidosis: A case report Georgia Vogiatzi, MD, MSc, PhD 1 st Cardiology Department, Hippokration Hospital, Athens Medical School Disclosures I have no relevant relationships

More information

Cardiology. Presented by: Dr Paul Bethell GP Lead for Planned Care

Cardiology. Presented by: Dr Paul Bethell GP Lead for Planned Care Cardiology Presented by: Dr Paul Bethell GP Lead for Planned Care 16 th April 2015 Integrated Cardiology Service for Ipswich and East Suffolk CCG IHT 6 consultants - all with specialist areas PCI CoW rapid

More information

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS

THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS 88 th ASMA ANNUAL SCIENTIFIC MEETING DENVER - CO April 30- May 4, 2017 THE NEW PLACE OF CARDIAC MRI IN AERONAUTICAL FITNESS S. BISCONTE (1), J. MONIN (2), N. HUIBAN (3), G. GUIU (2), S. NGUYEN (1), O.

More information

Coding Hints 2 nd Edition

Coding Hints 2 nd Edition Coding Hints 2 nd Edition Medicare s guidelines state, Code all documented conditions which co-exist at the time of the visit that require or affect patient care or treatment. Beyond the Basics Incomplete

More information

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009

Objectives. Systolic Heart Failure: Definitions. Heart Failure: Historical Perspective 2/7/2009 Objectives Diastolic Heart Failure and Indications for Echocardiography in the Asian Population Damon M. Kwan, MD UCSF Asian Heart & Vascular Symposium 02.07.09 Define diastolic heart failure and differentiate

More information

5 Important Things to Know About Heart Failure. Kia Afshar, MD

5 Important Things to Know About Heart Failure. Kia Afshar, MD 5 Important Things to Know About Heart Failure Kia Afshar, MD Disclosures I have no conflicts of interest to disclose I will not be discussing any off label medications and/or devices Objectives 1) Understand

More information